Boston Scientific (BSX) is a publicly traded Healthcare sector company. As of October 1, 2026, BSX trades at $43.69 with a market cap of $63.59B and a P/E ratio of 17.55. BSX moved -0.12% today. Year to date, BSX is -53.91%; over the trailing twelve months it is -55.29%. Its 52-week range spans $42.20 to $109.50. Analyst consensus is strong buy with an average price target of $58.58. Rallies surfaces BSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BSX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BSX recently traded at $43.69. Market cap is $63.59B. P/E ratio is 17.55. Revenue is $21.00B.
| Metric | Value |
|---|---|
| Price | $43.69 |
| Market Cap | $63.59B |
| P/E Ratio | 17.55 |
| EPS | $2.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $109.50 |
| 52-Week Low | $42.20 |
| Volume | 13.99M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.00B |
| Net Income | $3.67B |
| Gross Margin | 69.93% |
21 analysts cover BSX: 0 strong buy, 18 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $58.58.